Results 91 to 100 of about 465,229 (318)

DataSheet1_Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma.PDF [PDF]

open access: yes, 2022
Introduction: Increasing evidences have shown that hypoxia and the immune microenvironment play vital roles in the development of osteosarcoma. However, reliable gene signatures based on the combination of hypoxia and the immune status for prognostic ...
Wenshuo Zhang (164908)   +5 more
core   +1 more source

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer

open access: yesFrontiers in Pharmacology, 2022
Amlodipine is a Ca2+ channel blocker commonly used to cardiovascular diseases such as hypertension and angina; however, its anticancer effects in lung cancer A549 cells remain unknown. In the present study, we explored the antitumor effects and molecular
Bingjie Fu   +9 more
doaj   +1 more source

The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy [PDF]

open access: yes
The aryl hydrocarbon receptor (AhR) is a ubiquitous nuclear receptor with a broad range of functions, both in tumor cells and immune cells within the tumor microenvironment (TME).
Brian D. Griffith, Timothy L. Frankel
core   +1 more source

Mapping the BCSC-1 interactome in breast cancer

open access: yesScientific Reports
BCSC-1 (breast cancer suppressor candidate-1), the official gene symbol VWA5A (von Willebrand factor A domain containing 5 A), is downregulated in a variety of cancer types including breast cancer.
Yuan Ma   +10 more
doaj   +1 more source

CCR2 Enhances Anti-Intracellular Bacterial Infection by Modulating Macrophage Pyroptosis to Rebalance Th Immune Responses

open access: yesMicroorganisms
The treatment of intracellular bacterial infections such as Chlamydia remains a significant clinical challenge due to rising antibiotic resistance and persistent, immunopathology-driven tissue damage.
Shuaini Yang   +9 more
doaj   +1 more source

Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice

open access: yesNature Communications, 2020
The use of tumour exosome-activated dendritic cell (DC) immunotherapy shows promise for the treatment of large established tumours. Here, the authors generate alarmin HMGN1-attached tumour exosomes which significantly improve therapy efficacy by boosting
Bingfeng Zuo   +13 more
doaj   +1 more source

A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment

open access: yesFrontiers in Immunology, 2020
Increasing evidence has revealed that the initiation and progression of breast cancer are greatly affected by the immune environment. Neutrophils are the most abundant leucocytes in circulation and act as the spearhead in inflammation, including in ...
Wei Zhang   +13 more
doaj   +1 more source

RhoB affects colitis through modulating cell signaling and intestinal microbiome

open access: yesMicrobiome, 2022
Background The pathogenesis of inflammatory bowel diseases (IBD) is multifactorial, and diagnostic and treatment strategies for IBD remain to be developed. RhoB regulates multiple cell functions; however, its role in colitis is unexplored.
Jianming Yang   +12 more
doaj   +1 more source

Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy [PDF]

open access: yes
Background/Objectives: The tumor microenvironment (TME) has emerged as a significant prognostic factor. This study aimed to identify prognostic factors by combining clinicopathologic parameters and the TME biomarkers in patients who underwent surgery ...
Cho, Sang-Hee   +23 more
core   +1 more source

Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression [PDF]

open access: yes, 2023
Mycosis fungoides and Sézary syndrome are epidermotropic cutaneous lymphomas, and both of them are rare diseases. Mycosis fungoides is the most frequent primary cutaneous lymphoma.
Gabor Dobos   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy